Estefania Oliveros MD🫀

🔑 Cardiopulmonary exercise testing can assist in guiding medical therapy, guiding rehab, & creating exercise prescriptions to promote safe exercise & sport participation for patients w/ #CHD. Gain deeper insights into CPET in CHD 👉 bit.ly/42w9adp #ACCSportsCardio

This #JACCAdvances study found associations between self-reported work-related stressors & pregnancy complications in physicians & CVT members. Hospitals are encouraged to improve work conditions to support maternal, employee, & fetal outcomes jacc.org/doi/10.1016/j.… @EstefaniaOS

“approximately $800 million of lost productive time each year in the US alone”

On Record: Women and Pregnancy in the Cardiology Workforce tctmd.com/videos/on-reco… discussing pregnancy complications for women working in Cardiology from #ACCWIC @EstefaniaOS @DrJenniferCo_Vu @SabrinaIslamMD @snehanandy26 @DrToniyaSingh @Andrea_Price317 #ACCCVT

For women working in cardiology, how do you manage stress and complications during pregnancy while juggling a demanding career? @TCTMD_Caitlin sits down with @gina_lundberg, @KurrelmeyerMD, and @EstefaniaOS to discuss some solutions during the recent #ACC2026 in this On Record. Watch the full video now: tctmd.com/videos/on-reco…

@CheverePhD @DrJenniferCo_Vu @SrihariNaiduMD @JasonKatzMD @Babar_Basir @SandeepNathanMD Thank you !! It was a fantastic event

Four ACC Mix ’n Mingle programs! Four packed rooms! One big takeaway: people are hungry for connection, mentorship, and community. From WIC to FIT to Residents/Medical Students to Critical Care Cardiology, the energy was incredible! My favorite part is always seeing someone meet the mentor they have been hoping to connect with, and that smile that comes with it. That is what this is about! Thanks to all the mentors for these fantastic programs! I ♥️ my job!!!! #ACC26 #Cardiology #Mentorship

Thanks @zoll_cms and @CheverePhD for another successful #ACCWIC Mix and Mingle! 💙 @ACCinTouch

@WomenAs1 @iamritu @EstefaniaOS @anjalibthakkar @KurrelmeyerMD @NanditaScottMD @JACCJournals Proud that #ACCWIC WIC Council contributed to this important project!! #ACC26 @DrJenniferCo_Vu @EstefaniaOS @AmbreenMohamed @SabrinaIslamMD @loridanielsmd @snehanandy26 @nicolejsuttonmd @AroojKhanMD @KTamirisaMD @DrToniyaSingh @vtrivediMBBS

Nearly 40% of pregnancies among cardiology professionals involve complications, linked to inflexible schedules, added duties, and lack of support. Supporting women in cardiology isn’t optional. It’s essential for better care and stronger teams. jacc.org/doi/10.1016/j.…

Work-Related Stressors Associated With Complications in Pregnant CV Clinicians - American College of Cardiology acc.org/Latest-in-Card…

Hemodialysis Access–Related High-Output Heart Failure: From Mechanisms to Multidisciplinary Managemen #dfig1" target="_blank" rel="nofollow noopener">jacc.org/doi/10.1016/j.… #JACCCaseReports @JACCJournals

"It has been an honor to work with all of you, as well as our partners around the world, in our shared commitment to transforming heart health. My last duty as president, is to turn the College over to its next president, @Drroxmehran." - @ChrisKramerMD 👏 #ACC26

Welcoming our new ACC President Dr. Roxana Mehran @Drroxmehran

The results of the CADENCE trial are now published in @CircAHA with simultaneous presentation @ACCinTouch by @mardigomberg. CADENCE represents an important step forward for patients with combined post- and pre-capillary pulmonary hypertension (CpcPH) in the setting of HFpEF—an area with substantial unmet need. In this phase 2 study, treatment with sotatercept led to meaningful reductions in pulmonary vascular resistance (PVR), which translated into improved RV–PA coupling and reductions in natriuretic peptide levels. Importantly, these hemodynamic improvements were accompanied by favorable signals across multiple clinical domains for 0.3mg/kg dose: • Improvement in 6-minute walk distance • Improvements in New York Heart Association functional class (exploratory endpoint) • Prolonged time to clinical worsening (exploratory endpoint) In addition, there were reductions in left heart filling pressures, along with decreases in left atrial volume index—suggesting potential effects on cardiac remodeling and congestion. Strong safety profile with no excess bleeding compared to placebo (75% on systemic anticoagulation). Together, these findings reinforce the biologic rationale for targeting the pulmonary vasculature in CpcPH-HFpEF with sotatercept and provide strong momentum as we move toward phase 3. Grateful to the patients, investigators, and collaborators who made this work possible—and excited for what comes next. @jeanlucvachiery @MUSC_Cardiology ahajournals.org/doi/10.1161/CI…

@SashaPrisco @thenappanMD @ACCinTouch @UMNPHProgram @UMN_DCVM Thank you @thenappanMD and @jamazurek

Dr. Thenappan @thenappanMD participating in the @ACCinTouch #ACC26 fireside roundtable with pulmonary hypertension leaders! Honored to work with such a great mentor and role model! @UMNPHProgram @UMN_DCVM

🫀 Heart Failure Trials Quick Takes 🫀 Hear the highlights from SPIRIT-HF and CADENCE on #ACCAnywhere TV from #ACC26 with Estefanía Oliveros, MD, FACC ⬇️ Subscribe to ACC Anywhere for more content like this from premier events all year long: bit.ly/4bRyYEW

Join us at #ACC26 to discuss barriers in #CardioObstetrics & how we can advance equity & reduce maternal mortality in the U.S. #ACCRepOB #ACCCardioOB @ACCinTouch

Looking forward to this session at #ACC26 with some very amazing #ACCWIC !! “The impact of work related stressors on pregnancy outcomes of cardiologist and CVT members” 🗓️ Sunday 3/29 @ 1245 Education Zone theater 3 #ACCEarlyCareer

(Beta blockers) vs (OB, Cardiac-b and PharmD) #ACC26 #ACCRepOB #ACCCardioOB #CardioObstetrics